A to Z Summary Results - Patient Decision Aids - Ottawa Hospital Research Institute 


Decision Aid Summary

Title The BRCA 1/2 gene mutation test to evaluate the risks of breast and ovarian cancer ; Le dépistage des mutations génétiques BRCA1/2 pour évaluer les risques de cancer du sein et de l'ovaire
Audience Clinicians presenting information about taking the BRCA 1/2 gene mutation test.
Options included Taking the test.
Not taking the test.
Year of last update or review 2012
Format Web, paper, PDF
How to obtain Click here to view the decision aid on the developer website
Developer Anik Giguere
Where was it developed? anik.giguere@fmed.ulaval.ca
Laval University, Quebec city
Canada
Health condition Breast and Ovarian Cancer
Type of decision aid Screening
Language English, French
Based on IPDAS criteria (International Patient Decision Aid Standards) this decision aid (and/or supporting materials) meets:
7 out of 7 criteria to be defined as a patient decision aid
7 out of 9 criteria to lower the risk of making a biased decision
4 out of 4 other criteria for decision aids about screening or testing

Last modified: 2019-06-26.